Suppr超能文献

接受并转至区域性严重呼吸衰竭和静脉-静脉体外膜肺氧合(ECMO)服务:预测因素和结果。

Acceptance and transfer to a regional severe respiratory failure and veno-venous extracorporeal membrane oxygenation (ECMO) service: predictors and outcomes.

机构信息

Department of Critical Care, Queen Elizabeth University Hospital, Glasgow, UK.

Department of Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Anaesthesia. 2018 Feb;73(2):177-186. doi: 10.1111/anae.14083. Epub 2017 Nov 23.

Abstract

The use of extracorporeal membrane oxygenation for respiratory failure is high risk and resource intensive. In England, five centres provide this service and patients who are referred have four possible outcomes: declined transfer due to perceived futility; accepted in principle but remain at the referring centre with ongoing surveillance; retrieved using conventional ventilation; or retrieved on extracorporeal support. The decision-making process leading to these outcomes has not previously been examined. We evaluated referrals to one centre and identified factors associated with each decision outcome. Five hundred and sixty-four patients were analysed from January 2012 to October 2015. One hundred and fifty-seven patients were declined; multivariate analysis demonstrated associated factors to be: age (odds ratio (95% confidence interval) 1.05 (1.04-1.07)); immunocompromise (4.95 (2.58-9.67)); lactate (1.11 (1.01-1.22)); duration of ventilation (1.08 (1.04-1.14)); and cardiac failure (3.22 (1.04-10.51)). Factors associated with the decision to retrieve an accepted patient were: plateau pressure (1.05 (1.01-1.10)); ratio of arterial oxygen partial pressure to fractional inspired oxygen (0.89 (0.85-0.93)); partial pressure of carbon dioxide in arterial blood (1.13 (1.03-1.25)); and the absence of non-pulmonary infection (0.31 (0.15-0.61)). Only pH was independently associated with the decision to transfer on extracorporeal support (0.020 (0.002-0.017)). Six-month survival in the declined, non-retrieved, conventionally retrieved and extracorporeal-retrieved groups was 16.6%, 71.1%, 76.7% and 72.1%, respectively, substantially supporting the decision-making model. Survival in the accepted group exceeds that reported previously. However, a proportion of those declined do survive and some remotely managed patients die. This suggests the approach does not account for some important survival-determining factors.

摘要

体外膜肺氧合治疗呼吸衰竭的风险高且资源密集。在英国,有五个中心提供此项服务,被转介的患者有四种可能的结果:因认为无效而拒绝转移;原则上接受,但仍留在转介中心进行持续监测;通过常规通气恢复;或通过体外支持恢复。之前尚未研究导致这些结果的决策过程。我们评估了一个中心的转介情况,并确定了与每个决策结果相关的因素。从 2012 年 1 月至 2015 年 10 月,对 564 名患者进行了分析。157 名患者被拒绝;多变量分析表明相关因素为:年龄(优势比(95%置信区间)1.05(1.04-1.07));免疫抑制(4.95(2.58-9.67));乳酸(1.11(1.01-1.22));通气时间(1.08(1.04-1.14));和心力衰竭(3.22(1.04-10.51))。与决定取回接受治疗的患者相关的因素是:平台压(1.05(1.01-1.10));动脉血氧分压与吸入氧分数的比值(0.89(0.85-0.93));动脉血二氧化碳分压(1.13(1.03-1.25));和无非肺部感染(0.31(0.15-0.61))。只有 pH 值与决定体外支持转移独立相关(0.020(0.002-0.017))。在被拒绝、未取回、常规取回和体外取回的组中,6 个月生存率分别为 16.6%、71.1%、76.7%和 72.1%,这极大地支持了决策模型。接受组的生存率高于之前报告的生存率。然而,一部分被拒绝的患者确实存活下来,一些远程管理的患者死亡。这表明该方法没有考虑到一些重要的生存决定因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验